CN Patent

CN106714803B — 眼用混悬液制剂

Assigned to Sumitomo Pharma Co Ltd · Expires 2020-12-11 · 5y expired

What this patent protects

一种眼用混悬液制剂，其包含(R)‑(‑)‑2‑(4‑溴‑2‑氟苄基)‑1,2,3,4‑四氢吡咯并[1,2‑a]吡嗪‑4‑螺‑3'‑吡咯烷‑1,2',3,5'‑四酮，所述混悬液制剂能够避免由全身暴露引起的副作用，有效针对后眼疾病等，并且具有优异的稳定性。

USPTO Abstract

一种眼用混悬液制剂，其包含(R)‑(‑)‑2‑(4‑溴‑2‑氟苄基)‑1,2,3,4‑四氢吡咯并[1,2‑a]吡嗪‑4‑螺‑3'‑吡咯烷‑1,2',3,5'‑四酮，所述混悬液制剂能够避免由全身暴露引起的副作用，有效针对后眼疾病等，并且具有优异的稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN106714803B
Jurisdiction
CN
Classification
—
Expires
2020-12-11
Drug substance claim
No
Drug product claim
No
Assignee
Sumitomo Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.